Acorda Therapeutics, Inc. announced that Jeff Randall, who has been on the Board for many years, since 2006, and he's been a tremendous contributor, Head of the Audit Committee, he will be stepping down.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.879 USD | +9.88% | -2.33% | -94.17% |
15/04 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
2023 | Transcript : Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 |
1st Jan change | Capi. | |
---|---|---|
-94.17% | 529K | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.27% | 23.47B | |
-13.89% | 21.9B | |
-5.99% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- ACOR.Q Stock
- ACOR Stock
- News Acorda Therapeutics, Inc.
- Acorda Therapeutics, Inc. Announces Jeff Randall Step Down as Board and Head of Audit Committee